论文部分内容阅读
目的:观察奥扎格雷钠治疗急性脑梗死的临床疗效。方法:将脑血管病患者94例随机分成奥扎格雷钠治疗组(n=49)和对照组(n=45)。治疗组使用奥扎格雷钠;对照组使用维脑路通或血塞通等治疗,分别观察两组治疗前后临床神经功能缺损评分。结果:治疗组治愈好转率95.9%,对照组治愈好转率64.4%,两组比较差异有统计学意义(P<0.01)。结论:奥扎格雷钠治疗早期急性脑梗死,疗效显著,值得临床推广应用。
Objective: To observe the clinical efficacy of ozagrel sodium in the treatment of acute cerebral infarction. Methods: Ninety-four patients with cerebrovascular disease were randomly divided into the ozagrel sodium treatment group (n = 49) and the control group (n = 45). The treatment group used ozagrel sodium; the control group was treated with Venoruton or Xuesaitong, and the clinical neurological deficit scores of the two groups were observed before and after treatment. Results: The cured rate of cure was 95.9% in the treatment group and 64.4% in the control group, the difference between the two groups was statistically significant (P <0.01). Conclusion: Ozagrel sodium treatment of early acute cerebral infarction, a significant effect, worthy of clinical application.